Valeriu Bortnov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Valeriu Bortnov has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Deane F. Mosher
Department of Biomolecular Chemistry, University of Wisconsin-Madison, Madison, Wisconsin, United States of America
3 shared publications - Alex Bateman
European Molecular Biology Laboratory, European Bioinformatics Institute, (EMBL-EBI)
1 shared publication - Anna Huttenlocher
Department of Medical Microbiology and Immunology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706, USA
1 shared publication C. L. Nguyen
Department of Biomolecular Chemistry, University of Wisconsin, Madison, WI, USA
1 shared publicationD. F. Mosher
Department of Biomolecular Chemistry, University of Wisconsin, Madison, WI, USA
1 shared publicationD. S. Annis
Department of Biomolecular Chemistry, University of Wisconsin, Madison, WI, USA
1 shared publication
Latest Publications
- Open Access
- 28 May 2021
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 220 (8)
Myeloid-derived growth factor regulates neutrophil motility in interstitial tissue damage
Neutrophil recruitment to tissue damage is essential for host defense but can also impede tissue repair. The cues that differentially regulate neutrophil responses to tissue damage and infection remain unclear. Here, we report that the paracrine factor myeloid-derived growth factor (MYDGF) is induced by tissue damage and regulates neutrophil motility to damaged, but not infected, tissues in zebrafish larvae. Depletion of MYDGF impairs wound healing, and this phenotype is rescued by depleting neutrophils. Live imaging and photoconversion reveal impaired neutrophil reverse migration and inflammation resolution in mydgf mutants. We found that persistent neutrophil inflammation in tissues of mydgf mutants was dependent on the HIF-1α pathway. Taken together, our data suggest that MYDGF is a damage signal that regulates neutrophil interstitial motility and inflammation through a HIF-1α pathway in response to tissue damage.
- 28 May 2021
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 220 (8)
Open AccessMyeloid-derived growth factor regulates neutrophil motility in interstitial tissue damage
Neutrophil recruitment to tissue damage is essential for host defense but can also impede tissue repair. The cues that differentially regulate neutrophil responses to tissue damage and infection remain unclear. Here, we report that the paracrine factor myeloid-derived growth factor (MYDGF) is induced by tissue damage and regulates neutrophil motility to damaged, but not infected, tissues in zebrafish larvae. Depletion of MYDGF impairs wound healing, and this phenotype is rescued by depleting neutrophils. Live imaging and photoconversion reveal impaired neutrophil reverse migration and inflammation resolution in mydgf mutants. We found that persistent neutrophil inflammation in tissues of mydgf mutants was dependent on the HIF-1α pathway. Taken together, our data suggest that MYDGF is a damage signal that regulates neutrophil interstitial motility and inflammation through a HIF-1α pathway in response to tissue damage.
- Open Access
- 9 December 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-14
Solution structure of human myeloid-derived growth factor suggests a conserved function in the endoplasmic reticulum
Human myeloid-derived growth factor (hMYDGF) is a 142-residue protein with a C-terminal endoplasmic reticulum (ER) retention sequence (ERS). Extracellular MYDGF mediates cardiac repair in mice after anoxic injury. Although homologs of hMYDGF are found in eukaryotes as distant as protozoans, its structure and function are unknown. Here we present the NMR solution structure of hMYDGF, which consists of a short α-helix and ten β-strands distributed in three β-sheets. Conserved residues map to the unstructured ERS, loops on the face opposite the ERS, and the surface of a cavity underneath the conserved loops. The only protein or portion of a protein known to have a similar fold is the base domain of VNN1. We suggest, in analogy to the tethering of the VNN1 nitrilase domain to the plasma membrane via its base domain, that MYDGF complexed to the KDEL receptor binds cargo via its conserved residues for transport to the ER.
- 9 December 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-14
Open AccessSolution structure of human myeloid-derived growth factor suggests a conserved function in the endoplasmic reticulum
Human myeloid-derived growth factor (hMYDGF) is a 142-residue protein with a C-terminal endoplasmic reticulum (ER) retention sequence (ERS). Extracellular MYDGF mediates cardiac repair in mice after anoxic injury. Although homologs of hMYDGF are found in eukaryotes as distant as protozoans, its structure and function are unknown. Here we present the NMR solution structure of hMYDGF, which consists of a short α-helix and ten β-strands distributed in three β-sheets. Conserved residues map to the unstructured ERS, loops on the face opposite the ERS, and the surface of a cavity underneath the conserved loops. The only protein or portion of a protein known to have a similar fold is the base domain of VNN1. We suggest, in analogy to the tethering of the VNN1 nitrilase domain to the plasma membrane via its base domain, that MYDGF complexed to the KDEL receptor binds cargo via its conserved residues for transport to the ER.
- Open Access
- 1 August 2018
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 293 (34) , 13166-13175
Myeloid-derived growth factor is a resident endoplasmic reticulum protein
- 1 August 2018
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 293 (34) , 13166-13175
Open AccessMyeloid-derived growth factor is a resident endoplasmic reticulum protein
- 4 April 2017
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 47 (10) , 1263-1274
IL‐5‐stimulated eosinophils adherent to periostin undergo stereotypic morphological changes and ADAM8‐dependent migration
Summary: Background: IL‐5 causes suspended eosinophils to polarize with filamentous (F)‐actin and granules at one pole and the nucleus in a specialized uropod, the “nucleopod,” which is capped with P‐selectin glycoprotein ligand‐1 (PSGL‐1). IL‐5 enhances eosinophil adhesion and migration on periostin, an extracellular matrix protein upregulated in asthma by type 2 immunity mediators.Objective: Determine how the polarized morphology evolves to foster migration of IL‐5‐stimulated eosinophils on a surface coated with periostin.Methods: Blood eosinophils adhering to adsorbed periostin were imaged at different time points by fluorescent microscopy, and migration of eosinophils on periostin was assayed.Results: After 10 minutes in the presence of IL‐5, adherent eosinophils were polarized with PSGL‐1 at the nucleopod tip and F‐actin distributed diffusely at the opposite end. After 30‐60 minutes, the nucleopod had dissipated such that PSGL‐1 was localized in a crescent or ring away from the cell periphery, and F‐actin was found in podosome‐like structures. The periostin layer, detected with monoclonal antibody Stiny‐1, shown here to recognize the FAS1 4 module, was cleared in wide areas around adherent eosinophils. Clearance was attenuated by metalloproteinase inhibitors or antibodies to disintegrin metalloproteinase 8 (ADAM8), a major eosinophil metalloproteinase previously implicated in asthma pathogenesis. ADAM8 was not found in podosome‐like structures, which are associated with proteolytic activity in other cell types. Instead, immunoblotting demonstrated proteoforms of ADAM8 that lack the cytoplasmic tail in the supernatant. Anti‐ADAM8 inhibited migration of IL‐5‐stimulated eosinophils on periostin.Conclusions and Clinical Relevance: Migrating IL‐5‐activated eosinophils on periostin exhibit loss of nucleopodal features and appearance of prominent podosomes along with clearance of the Stiny‐1 periostin epitope. Migration and epitope clearance are both attenuated by inhibitors of ADAM8. We propose, therefore, that eosinophils remodel and migrate on periostin‐rich extracellular matrix in the asthmatic airway in an ADAM8‐dependent manner, making ADAM8 a possible therapeutic target.
- 4 April 2017
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 47 (10) , 1263-1274
IL‐5‐stimulated eosinophils adherent to periostin undergo stereotypic morphological changes and ADAM8‐dependent migration
Summary: Background: IL‐5 causes suspended eosinophils to polarize with filamentous (F)‐actin and granules at one pole and the nucleus in a specialized uropod, the “nucleopod,” which is capped with P‐selectin glycoprotein ligand‐1 (PSGL‐1). IL‐5 enhances eosinophil adhesion and migration on periostin, an extracellular matrix protein upregulated in asthma by type 2 immunity mediators.Objective: Determine how the polarized morphology evolves to foster migration of IL‐5‐stimulated eosinophils on a surface coated with periostin.Methods: Blood eosinophils adhering to adsorbed periostin were imaged at different time points by fluorescent microscopy, and migration of eosinophils on periostin was assayed.Results: After 10 minutes in the presence of IL‐5, adherent eosinophils were polarized with PSGL‐1 at the nucleopod tip and F‐actin distributed diffusely at the opposite end. After 30‐60 minutes, the nucleopod had dissipated such that PSGL‐1 was localized in a crescent or ring away from the cell periphery, and F‐actin was found in podosome‐like structures. The periostin layer, detected with monoclonal antibody Stiny‐1, shown here to recognize the FAS1 4 module, was cleared in wide areas around adherent eosinophils. Clearance was attenuated by metalloproteinase inhibitors or antibodies to disintegrin metalloproteinase 8 (ADAM8), a major eosinophil metalloproteinase previously implicated in asthma pathogenesis. ADAM8 was not found in podosome‐like structures, which are associated with proteolytic activity in other cell types. Instead, immunoblotting demonstrated proteoforms of ADAM8 that lack the cytoplasmic tail in the supernatant. Anti‐ADAM8 inhibited migration of IL‐5‐stimulated eosinophils on periostin.Conclusions and Clinical Relevance: Migrating IL‐5‐activated eosinophils on periostin exhibit loss of nucleopodal features and appearance of prominent podosomes along with clearance of the Stiny‐1 periostin epitope. Migration and epitope clearance are both attenuated by inhibitors of ADAM8. We propose, therefore, that eosinophils remodel and migrate on periostin‐rich extracellular matrix in the asthmatic airway in an ADAM8‐dependent manner, making ADAM8 a possible therapeutic target.